0069-0342 : Zirabev 400 mg/16ml Intravenous Injection, Solution

Labeler: Pfizer Laboratories Div Pfizer Inc
Product Type: Human Prescription Drug
Drug Name:  Zirabev
Dosage Form: Intravenous Injection, Solution
Application #: BLA761099
Rev. Date: 

NDC Package Codes:

  • 0069-0342-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (0069‑0342‑01) > 16 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Bevacizumab

Dosage Strength:

  • 400 mg/16mL

Pharmaceutical Classes:

  • Vascular Endothelial Growth Factor Inhibitor [EPC]
  • Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
  • Vascular Endothelial Growth Factor Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0069-0315 Zirabev 100 mg/4ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc


Scan the QR code below to easily reference this data in the future:

NDC 0069-0342 QR Code

< Prev: 0069-0338Next: 0069-0400 >

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 February 2020.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA